Lates News

It has come to our attention that the GIP/GLP-1 drug, tirzepatide injection, has been approved by the China National Medical Products Administration (NMPA) to become the first and currently only prescription drug for treating moderate to severe obstructive sleep apnea (OSA) in adult obese patients.